M&T Bank’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4
| Closed | -$4 | – | 1613 |
|
|
2023
Q4 | $4 | Sell |
4
-159
| -98% | -$8.35K | ﹤0.01% | 1638 |
|
|
2023
Q3 | $326 | Buy |
163
+4
| +3% | +$245 | ﹤0.01% | 1590 |
|
|
2023
Q2 | $5.25K | Sell |
159
-26
| -14% | -$1.74K | ﹤0.01% | 1607 |
|
|
2023
Q1 | $10.2K | Buy |
+185
| New | +$13K | ﹤0.01% | 1614 |
|
|
2022
Q4 | – | Sell |
-409
| Closed | -$71K | – | 1607 |
|
|
2022
Q3 | $71K | Buy |
409
+138
| +51% | +$10K | ﹤0.01% | 1525 |
|
|
2022
Q2 | $15K | Sell |
271
-10
| -4% | -$762 | ﹤0.01% | 1539 |
|
|
2022
Q1 | $108K | Buy |
281
+21
| +8% | +$1.41K | ﹤0.01% | 1426 |
|
|
2021
Q4 | $51K | Buy |
260
+8
| +3% | +$469 | ﹤0.01% | 1526 |
|
|
2021
Q3 | $18K | Buy |
252
+2
| +0.8% | +$132 | ﹤0.01% | 1527 |
|
|
2021
Q2 | $24K | Buy |
250
+163
| +187% | +$10.6K | ﹤0.01% | 1546 |
|
|
2021
Q1 | $7K | Buy |
87
+1
| +1% | +$62 | ﹤0.01% | 1521 |
|
|
2020
Q4 | $7K | Buy |
86
+38
| +79% | +$2.34K | ﹤0.01% | 1651 |
|
|
2020
Q3 | $7K | Buy |
48
+7
| +17% | +$421 | ﹤0.01% | 1558 |
|
|
2020
Q2 | $8K | Hold |
41
| – | – | ﹤0.01% | 1542 |
|
|
2020
Q1 | $7K | Hold |
41
| – | – | ﹤0.01% | 1517 |
|
|
2019
Q4 | $20K | Buy |
41
+19
| +86% | +$1.09K | ﹤0.01% | 1356 |
|
|
2019
Q3 | $4K | Buy |
+22
| New | +$1.03K | ﹤0.01% | 1576 |
|
|
2019
Q2 | – | Sell |
-20
| Closed | -$1K | – | 1615 |
|
|
2019
Q1 | $1K | Buy |
20
+1
| +5% | +$50 | ﹤0.01% | 1573 |
|
|
2018
Q4 | $1K | Hold |
19
| – | – | ﹤0.01% | 1418 |
|
|
2018
Q3 | $7K | Hold |
19
| – | – | ﹤0.01% | 1517 |
|
|
2018
Q2 | $3K | Hold |
19
| – | – | ﹤0.01% | 1524 |
|
|
2018
Q1 | $7K | Hold |
19
| – | – | ﹤0.01% | 1534 |
|
|
2017
Q4 | $6K | Hold |
19
| – | – | ﹤0.01% | 1586 |
|
|
2017
Q3 | $9K | Hold |
19
| – | – | ﹤0.01% | 1577 |
|
|
2017
Q2 | $3K | Hold |
19
| – | – | ﹤0.01% | 1572 |
|
|
2017
Q1 | $1K | Sell |
19
-18
| -49% | -$987 | ﹤0.01% | 1639 |
|
|
2016
Q4 | $4K | Buy |
37
+10
| +37% | +$547 | ﹤0.01% | 1658 |
|
|
2016
Q3 | $2K | Buy |
27
+15
| +125% | +$964 | ﹤0.01% | 1682 |
|
|
2016
Q2 | $14K | Sell |
12
-2,388
| -100% | -$169K | ﹤0.01% | 1623 |
|
|
2016
Q1 | $7K | Buy |
2,400
+1,500
| +167% | +$94.6K | ﹤0.01% | 1668 |
|
|
2015
Q4 | $11K | Hold |
900
| – | – | ﹤0.01% | 1685 |
|
|
2015
Q3 | $4K | Hold |
900
| – | – | ﹤0.01% | 1760 |
|
|
2015
Q2 | $9K | Sell |
900
-3,200
| -78% | -$211K | ﹤0.01% | 2024 |
|
|
2015
Q1 | $10K | Sell |
4,100
-4,200
| -51% | -$263K | ﹤0.01% | 2002 |
|
|
2014
Q4 | $13K | Buy |
8,300
+6,900
| +493% | +$389K | ﹤0.01% | 2028 |
|
|
2014
Q3 | $1K | Buy |
+1,400
| New | +$69.9K | ﹤0.01% | 2253 |
|
Other funds holding BMY
VCM
VPM
M&T Bank's BMY Position: Q1 2026 in Review
M&T Bank reduced its Bristol-Myers Squibb (BMY) stake by 0.63% in Q1 2026, selling an estimated $283K and leaving 771,822 shares worth $46.8M. The position accounts for 0.16% of the portfolio, ranked #114.
M&T Bank first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $120M in Q2 2015. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- M&T Bank held 771,822 shares of Bristol-Myers Squibb worth $46.8M as of Q1 2026.
- M&T Bank sold 4,861 Bristol-Myers Squibb shares in Q1 2026, an estimated $283K.
- Bristol-Myers Squibb made up 0.16% of M&T Bank's portfolio in Q1 2026, its #114 holding.
- M&T Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- M&T Bank's Bristol-Myers Squibb position peaked at $120M in Q2 2015.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.